Cargando…
Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials
The development of new blood vessels is a crucial step in breast cancer growth, progression and dissemination, making it a promising therapeutic target. Breast cancer has a heterogeneous nature and the diversity of responsible angiogenic pathways between different tumors has been studied for many ye...
Autores principales: | Fakhrejahani, Elham, Toi, Masakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941646/ https://www.ncbi.nlm.nih.gov/pubmed/24474817 http://dx.doi.org/10.1093/jjco/hyt201 |
Ejemplares similares
-
Tumor Angiogenesis: Pericytes and Maturation Are Not to Be Ignored
por: Fakhrejahani, Elham, et al.
Publicado: (2012) -
Clinical Trials of Antiangiogenesis Therapy on Gastric Cancer
por: Wu, Li Cun, et al.
Publicado: (2008) -
Antiangiogenesis therapy: an update after the first decade
por: De Falco, Sandro
Publicado: (2014) -
Surrogate markers in antiangiogenesis clinical trials
por: Davis, D W, et al.
Publicado: (2003) -
Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer()
por: Ribatti, Domenico, et al.
Publicado: (2016)